ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,469
Screening encounters
1,550
Diagnostic referrals
295
Outstanding pathways
142

Screening pathway

  1. Screening1,550Encounters
  2. Positive finding519Documented findings
  3. Referral295Diagnostic referrals
  4. Follow-up310Diagnostic visits
  5. Outcome153Resolved pathways

Stage totals use different units. Pending pathways: 142. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2025-09-28, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22

Referral-time risk

No matching referral was available at this observation date.

Screened participants

1469 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2054 · Expanded synthetic participant 2054Site D — Community Engagement Programme
EXP-2056 · Expanded synthetic participant 2056Site B — Peri-Urban Access Programme
EXP-2058 · Expanded synthetic participant 2058Site D — Community Engagement Programme
EXP-2067 · Expanded synthetic participant 2067Site C — Rural Outreach Programme
EXP-2068 · Expanded synthetic participant 2068Site B — Peri-Urban Access Programme
EXP-2069 · Expanded synthetic participant 2069Site A — Urban Referral Hub
EXP-2070 · Expanded synthetic participant 2070Site E — Resource-Constrained Navigation Programme
EXP-2075 · Expanded synthetic participant 2075Site E — Resource-Constrained Navigation Programme
EXP-2078 · Expanded synthetic participant 2078Site B — Peri-Urban Access Programme
EXP-2079 · Expanded synthetic participant 2079Site A — Urban Referral Hub
EXP-2080 · Expanded synthetic participant 2080Site A — Urban Referral Hub
EXP-2087 · Expanded synthetic participant 2087Site C — Rural Outreach Programme
EXP-2091 · Expanded synthetic participant 2091Site A — Urban Referral Hub
EXP-2095 · Expanded synthetic participant 2095Site D — Community Engagement Programme
EXP-2096 · Expanded synthetic participant 2096Site D — Community Engagement Programme
EXP-2098 · Expanded synthetic participant 2098Site D — Community Engagement Programme
EXP-2100 · Expanded synthetic participant 2100Site E — Resource-Constrained Navigation Programme
EXP-2113 · Expanded synthetic participant 2113Site E — Resource-Constrained Navigation Programme
EXP-2115 · Expanded synthetic participant 2115Site A — Urban Referral Hub
EXP-2121 · Expanded synthetic participant 2121Site C — Rural Outreach Programme
EXP-2122 · Expanded synthetic participant 2122Site A — Urban Referral Hub
EXP-2130 · Expanded synthetic participant 2130Site D — Community Engagement Programme
EXP-2132 · Expanded synthetic participant 2132Site C — Rural Outreach Programme
EXP-2137 · Expanded synthetic participant 2137Site B — Peri-Urban Access Programme
EXP-2138 · Expanded synthetic participant 2138Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
661
HPV DNA
666
Cytology
223

Navigation activity

Barrier documented
241
Contact attempt
428
Navigation intervention
98
Diagnostic booking
355
Diagnostic visit
310

Documented barriers

Contact difficulty
72
Transport difficulty
82
Appointment coordination
87

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.